What recommended tools are short, easy to administer & assist in predicting opioid use disorder?

Knowledge Library published on March 29, 2013 in Assess & Monitor
Download Transcript Download Audio
Lynn R. Webster, MD, FACPM, FASAM
Medical Director
CRILifetree
Co-Founder, LifeSource
Salt Lake City, Utah
Hi. I am Lynn Webster, medical director of CRILifetree Clinical Research in Salt Lake City. Physicians have a very limited amount of time to assess patients, but it is critically important that we do a risk assessment. There are tools available. The Opioid Risk Tool and the SOAPP are two examples that help us understand in a very quick fashion the potential risk of somebody developing or displaying aberrant behaviors if they are prescribed an opioid. Once somebody is on an opioid, the COMM is another tool which you can find on Emerging Solutions in Pain website and I think that using a urine drug testing as well as the prescription monitoring tools are very helpful in trying to assess the risk that somebody might display aberrant behavior.
Last modified: February 1, 2013
Related Items by Category
Does genetic makeup of an individual influence patient's vulnerability to an opioid use disorder?
Knowledge Library published on May 31, 2013 in Assess & Monitor
What are the four domains to consider for assessing pain outcomes?
Knowledge Library published on May 17, 2013 in Assess & Monitor
Can UDT be used to confirm diagnosis of drug addiction or physical dependence?
Knowledge Library published on June 15, 2012 in Assess & Monitor
How do you assess analgesia in patients with cognitive impairment or limited ability to communicate?
Knowledge Library published on May 25, 2012 in Assess & Monitor
How does pain education differ from other types of education?
Knowledge Library published on May 11, 2012 in Assess & Monitor
What does the absence of an expected drug in urine mean?
Knowledge Library published on April 13, 2012 in Assess & Monitor
Can UDT results be a sole indicator of adherence to prescribed opioids?
Knowledge Library published on March 2, 2012 in Assess & Monitor
Should clinicians require UDT on only those patients who are exhibiting aberrant behaviors?
Knowledge Library published on November 11, 2011 in Assess & Monitor
Why should we use UDT in our pain practices?
Knowledge Library published on September 9, 2011 in Assess & Monitor
Related Items by Author
When a patient displays aberrant behaviors, should clinicians assume they are abusing their opioid?
Lynn R. Webster, MD, FACPM, FASAM
Knowledge Library published on April 26, 2013 in Practice
Do all substance abusers present with the same behaviors and abuse patterns?
Lynn R. Webster, MD, FACPM, FASAM
Knowledge Library published on December 7, 2012 in Practice
What can be done to reduce deaths related to prescription medications?
Lynn R. Webster, MD, FACPM, FASAM
Knowledge Library published on March 9, 2012 in Safety/ADRs/SEs
What critical educational points should be covered to teach safe use to the patient?
Lynn R. Webster, MD, FACPM, FASAM
Knowledge Library published on February 10, 2012 in Safety/ADRs/SEs